SecBot SecBot
8-K ·Filed Sep 8, 2026

KURA

Kura Oncology, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago SEC0001193125-26-384363
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

This is a routine CFO appointment with no immediate trading implications. Monitor for any future strategic or financial updates from the new CFO, but no near-term catalyst is expected from this filing.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20
Entry
$12.52
T+0 close · Sep 8, 2026 · via day close
Latest settled
−15.89%
T+20 · $10.53 · next T+60 in 15d
Vs SPY
−17.61%
α at T+20
Latest observation
−29.36%
T+48 · FF3 residual α
  1. T+0 · Sep 8 $12.52entry
  2. T+1 · 2mo ago −3.43%α −2.97% · $12.09
  3. T+5 · 2mo ago −9.74%α −8.63% · $11.30
  4. T+20 · 6w ago −15.89%α −17.61% · $10.53
  5. T+49 · todayOpen
  6. T+60 · in 15d Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Kura Oncology appointed Jennifer Fulk as CFO, replacing Troy E. Wilson and Thomas Doyle in those roles, effective September 8, 2026. This is a routine executive appointment with standard compensation terms, including a $550,000 base salary, an option for 450,000 shares, and a performance-based RSU award. No red flags such as unexpected departures or resignations are present, making this a neutral event.

Key Facts

  • Jennifer Fulk appointed CFO, principal financial officer, and principal accounting officer effective September 8, 2026.
  • Annual base salary of $550,000, with eligibility for an annual discretionary bonus of up to 45% of base salary.
  • Received an option to purchase 450,000 shares vesting over 4 years and a performance-based RSU award covering 173,438 shares.
  • No unexpected departures or resignations; the appointment is a standard executive change.

Financial Impact

Standard executive compensation package with $550,000 base salary and equity awards totaling 623,438 shares (450,000 options + 173,438 PSUs). No material financial impact.

Risk Factors

  • No material risks identified from this routine executive change.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (22 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-384363
Document: 0001193125-26-384363-index-headers.html0001193125-26-384363
Document: 0001193125-26-384363-index.html0001193125-26-384363
Document: 0001193125-26-384363.txt0001193125-26-384363

Track record

29 reports on KURA

Performance horizon

6 of 9 bullish or bearish reports moved the stock their way by T+60. Best: +52.28% at T+60 after the Jun 3, 2026 report. 10 of 14 went positive at some point.

Filters
  1. Nov 16, 2026today Insider Buy Bullish 5/10 Entry $7.15 Now $7.09 −0.84% settles Feb 16
  2. Nov 16, 2026today 144 Neutral 3/10 Entry $7.15 Now $7.09 −0.84% settles Feb 16
  3. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $7.15 Now $7.09 −0.84% settles Feb 16
  4. Nov 10, 20266d ago S-3ASR Neutral 4/10 Entry $7.73 Now $7.09 −8.28% settles Feb 9
  5. Nov 10, 20266d ago Press Release Neutral 5/10 Entry $7.73 Now $7.09 −8.28% settles Feb 9
  6. Nov 4, 202612d ago Press Release Neutral 4/10 Entry $7.61 Now $7.09 −6.83% settles Feb 2
  7. Sep 29, 20266w ago Insider Cluster Bearish 5/10 Entry $10.71 Now $7.09 +33.80% settles Dec 24
  8. Sep 29, 20266w ago Press Release Bullish 6/10 Entry $10.81 Now $7.09 −34.38% settles Dec 23
  9. Sep 9, 20269w ago 8-K Bullish 6/10 Entry $12.09 Now $7.09 −41.36% settles Dec 3
  10. Sep 8, 20269w ago 8-K Neutral 2/10 Viewing Entry $12.52 Now $7.09 −43.37% settles Dec 2
Showing 10 of 29

US Market Status

Market Closed · Opens in 7h 2m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 9, 2026